Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

14 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility NCT00876031 Soft Tissue Sarcoma - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 19 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00876031

Sarcoma NCT01247571 Pre-Study - GOG-0230: Fast Fact Sheet for Protocol 0230-D (Uterus) - 3174263v1.0 - GOG-0230: Fast Fact Sheet for Protocol 0230-D (Uterus)

- 20/9/21 - 1 formulario, 3 itemgroups, 91 items, 1 idioma
Itemgroups: Patient Information, Eligibility 1, Provide comments about this Fast Fact Sheet
GOG-0230: Fast Fact Sheet for Protocol 0230-D (Uterus) Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=97F2A353-AB36-7B12-E040-BB89AD432C3D

Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369 - Pathology Report

- 31/12/19 - 1 formulario, 6 itemgroups, 20 items, 1 idioma
Itemgroups: Administrative data, Primary, Histology Type, Histologic Grade, Specimens, Secondary
Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer 

Eligibility Stage I Adult Soft Tissue Sarcoma NCT00896961

- 24/4/16 - 1 formulario, 1 itemgroup, 19 items, 1 idioma
Itemgroup: Inclusion Criteria
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00896961

AEWS0331: Eligibility Worksheet DRKS00003782 NCT00020566 - AEWS0331: Eligibility Worksheet NCT00020566

- 3/7/15 - 1 formulario, 4 itemgroups, 13 items, 1 idioma
Itemgroups: Header, Patient demographics, Comments, CCRR MODULE
AEWS0331: Eligibility Worksheet NCT00020566 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BED15863-3519-3BB6-E034-0003BA12F5E7

Toxicity - Sarcoma - Adverse Event Form - 2286753v3.0 - Sarcoma - Adverse Event Form

- 9/1/15 - 1 formulario, 4 itemgroups, 21 items, 1 idioma
Itemgroups: CRF Header, Sarcoma: Form Administration, Sarcoma: Adverse Events, Comments
Sarcoma - Adverse Event Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE953EB7-2CB8-2814-E034-0003BA12F5E7

Sarcoma NCT01533207 Follow-Up - Gynecologic Oncology Group Follow-Up Form (Form Q) - 2727848v1.0 - Gynecologic Oncology Group Follow-Up Form (Form Q)

- 9/1/15 - 1 formulario, 8 itemgroups, 32 items, 1 idioma
Itemgroups: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS
Gynecologic Oncology Group Follow-Up Form (Form Q) Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=45808A16-A3A1-20DA-E044-0003BA3F9857

Sarcoma Pre-Study - GOG-0231D: Fast Fact Sheet for Protocol 0231-D (Uterus) - 3307969v1.0 - GOG-0231D: Fast Fact Sheet for Protocol 0231-D (Uterus)

- 9/1/15 - 1 formulario, 3 itemgroups, 73 items, 1 idioma
Itemgroups: Patient Information, Eligibility, Provide comments about this Fast Fact Sheet
GOG-0231D: Fast Fact Sheet for Protocol 0231-D (Uterus) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1F54BBE-5B83-73AD-E040-BB89AD4338D5

Follow-Up - Sarcoma - Functional Evaluation Form for Extremity Primary - 2290878v3.0 - Sarcoma - Functional Evaluation Form for Extremity Primary

- 9/1/15 - 1 formulario, 3 itemgroups, 22 items, 1 idioma
Itemgroups: CRF Header, Sarcoma: Form Administration, Sarcoma: Functional Evaluation
Sarcoma - Functional Evaluation Form for Extremity Primary Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E298AD03-E4A8-0934-E034-0003BA12F5E7

Treatment - Sarcoma - Treatment Reporting Period Form - 2290511v3.0 - Sarcoma - Treatment Reporting Period Form

- 9/1/15 - 1 formulario, 5 itemgroups, 40 items, 1 idioma
Itemgroups: CRF Header, Sarcoma: Treatment Reporting Period, Sarcoma: Treatment Summary - Radiation Therapy, Sarcoma: Treatment Schedule - Systemic Therapy, Comments
Sarcoma - Treatment Reporting Period Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E298B865-351E-09AF-E034-0003BA12F5E7

On-Study - Bone Sarcoma - On-Study Form Recurrent Treatment - 2290047v3.0 - Bone Sarcoma - On-Study Form Recurrent Treatment

- 9/1/15 - 1 formulario, 7 itemgroups, 63 items, 1 idioma
Itemgroups: CRF Header, Sarcoma: Form Administration, Bone Sarcoma: Recurrent Disease Description, Bone Sarcoma: Prior Health History, Sarcoma: Prior Treatment, Sarcoma: Prior Treatment - Systemic Regimens, Comments
Bone Sarcoma - On-Study Form Recurrent Treatment Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E20A02D1-D3E7-176A-E034-0003BA12F5E7

Follow-Up - Sarcoma - Follow-Up Form - 2290562v3.0 - Sarcoma - Follow-Up Form

- 9/1/15 - 1 formulario, 7 itemgroups, 32 items, 1 idioma
Itemgroups: CRF Header, Sarcoma: Follow-up Reporting Period, Sarcoma: Vital Status, Sarcoma: Disease Follow-up Status, Sarcoma: Notice of Progression, Sarcoma: Notice of New Primary, Sarcoma: Long-Term Toxicity
Sarcoma - Follow-Up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E405767F-8C6A-3312-E034-0003BA3F9857

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial